Pyruvate kinase muscle isoenzyme 2 (PKM2) is predicted to be a highly likely target of miR-122-5p, and a study of renal cancer found that overexpressed miR-122-5p can negatively regulate PKM2 [45], which is consistent with our prediction. This evidence concerns the gene PKM and renal carcinoma.